Fudan University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
Expression of Molecular Markers in Circulating Tumor Cells of Metastatic Castration-Resistant Prostate Cancer
- Conditions
- Prostate Cancer Metastatic
- First Posted Date
- 2017-03-24
- Last Posted Date
- 2017-05-01
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 100
- Registration Number
- NCT03089099
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
The Value of Diffusion-weighted Imaging in Evaluating the Early Efficacy of Liver Metastasis in Colorectal Cancer
Not Applicable
- Conditions
- DWI-MRI
- Interventions
- Device: Diffusion weighted magnetic resonance imaging
- First Posted Date
- 2017-03-23
- Last Posted Date
- 2017-03-23
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 100
- Registration Number
- NCT03088163
- Locations
- 🇨🇳
Fudan University Cancer Hospital, ShangHai, Shanghai, China
Metronomic PLD in Patients With Primary Endocrine Resistant ABC
- First Posted Date
- 2017-03-07
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 46
- Registration Number
- NCT03071926
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, China
The Study of Targeted NY-ESO-1 T Cell Receptor (TCR) Genetic Modified Autologous T Cells Treatment of Advanced Solid Tumors
Not Applicable
- Conditions
- Advanced Malignant Solid Tumors
- Interventions
- Other: TCR - T cell therapy
- First Posted Date
- 2017-02-09
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 15
- Registration Number
- NCT03047811
- Locations
- 🇨🇳
Cancer hospital Fudan University, Shanghai, Shanghai, China
Safety and Risk Assessment of Obese Parturient Underwent Cesarean Section(CS) Delivery Under Different Anesthesia Ways
Not Applicable
Completed
- Conditions
- Cesarean Section
- Interventions
- Procedure: anesthesia
- First Posted Date
- 2016-12-26
- Last Posted Date
- 2016-12-26
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 900
- Registration Number
- NCT03002636
A Study of SBRT for OligoMetastatic ESCC
Not Applicable
Completed
- Conditions
- Esophageal Squamous Cell Carcinoma Metastatic
- Interventions
- Radiation: SBRT
- First Posted Date
- 2016-12-22
- Last Posted Date
- 2021-01-26
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 34
- Registration Number
- NCT03000816
- Locations
- 🇨🇳
Fudan Universtiy Shanghai Cancer Center, Shanghai, Shanghai, China
Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma (ECTOP-1002)
- First Posted Date
- 2016-12-02
- Last Posted Date
- 2023-07-20
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 80
- Registration Number
- NCT02980991
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer
Phase 3
Completed
- Conditions
- Breast Cancer Female
- Interventions
- Drug: letrozole, leuprorelin, fluorouracil, epirubicin, cyclophosphamide, docetaxelDrug: fluorouracil, epirubicin, cyclophosphamide, docetaxel
- First Posted Date
- 2016-12-02
- Last Posted Date
- 2017-11-13
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 249
- Registration Number
- NCT02980965
- Locations
- 🇨🇳
Cancer Hospital/ Institute, Fudan University, Shanghai, Shanghai, China
Transanal Tube Drainage in Endoscopic Submucosal Dissection of the Colorectal Tumor
Not Applicable
- Conditions
- Colorectal Tumor
- Interventions
- Device: Transanal Tube Drainage
- First Posted Date
- 2016-11-25
- Last Posted Date
- 2016-11-25
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 1200
- Registration Number
- NCT02973490
- Locations
- 🇨🇳
Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China
Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)
Phase 3
- Conditions
- Locally Advanced Colorectal Cancer
- Interventions
- Drug: Standard adjuvant systemic chemotherapyProcedure: Hyperthermic intraperitoneal chemotherapy (HIPEC) with oxaliplatinProcedure: Hyperthermic intraperitoneal chemotherapy (HIPEC) with raltitrexed
- First Posted Date
- 2016-11-16
- Last Posted Date
- 2018-06-19
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 147
- Registration Number
- NCT02965248
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath